New hair loss drug shows promise in early trial
NCT ID NCT07076706
First seen Mar 08, 2026 · Last updated Apr 28, 2026 · Updated 10 times
Summary
This study tested a new drug called CG2001 in 110 Chinese men with male pattern baldness. The goal was to see if it helps regrow hair and to find the best dose for future studies. Participants used the drug or a placebo for 24 weeks, and doctors measured changes in hair count.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA (AGA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Tongren Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, China
-
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
-
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China
-
Huashan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, China
-
Jiangxi Provincial Dermatology Hospital
Nanchang, Jiangxi, China
-
Peking University People's Hospital
Beijing, China
-
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
-
Xiangya Hospital of Central South University
Changsha, Hunan, China
Conditions
Explore the condition pages connected to this study.